These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12099567)

  • 1. A new method for attenuation coefficient measurement in the liver: comparison with the spectral shift central frequency method.
    Fujii Y; Taniguchi N; Itoh K; Shigeta K; Wang Y; Tsao JW; Kumasaki K; Itoh T
    J Ultrasound Med; 2002 Jul; 21(7):783-8. PubMed ID: 12099567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation coefficient measurement in the thyroid.
    Fujii Y; Taniguchi N; Itoh K; Omoto K
    J Ultrasound Med; 2003 Oct; 22(10):1067-73. PubMed ID: 14606563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound backscatter and attenuation in human liver with diffuse disease.
    Lu ZF; Zagzebski JA; Lee FT
    Ultrasound Med Biol; 1999 Sep; 25(7):1047-54. PubMed ID: 10574336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on frequency-dependent attenuation in the normal liver and spleen and in liver diseases, using the spectral-shift zero-crossing method.
    Itoh K; Yasuda Y; Suzuki O; Itoh H; Itoh T; Tsao JW; Konishi T; Koyano A
    J Clin Ultrasound; 1988 Oct; 16(8):553-62. PubMed ID: 3152399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of ultrasound in normal liver and diffuse liver disease in vivo.
    Maklad NF; Ophir J; Balsara V
    Ultrason Imaging; 1984 Apr; 6(2):117-25. PubMed ID: 6539974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound attenuation measurements of the liver in vivo using a commercial sector scanner.
    Garra BS; Shawker TH; Nassi M; Russell MA
    Ultrason Imaging; 1984 Oct; 6(4):396-407. PubMed ID: 6399170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of ultrasound attenuation and histopathological parameters of the liver in chronic diffuse liver diseases.
    Szebeni A; Tolvaj G; Zalatnai A
    Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):37-42. PubMed ID: 16357617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and liver disease: evaluation of fatty infiltration of the liver using ultrasonic attenuation.
    Fusamoto H; Suzuki K; Hayashi N; Sasaki Y; Kono M; Kasahara A; Kamada T
    J Nutr Sci Vitaminol (Tokyo); 1991 Dec; 37 Suppl():S71-7. PubMed ID: 1820448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation Coefficient Measurement Using a High-Frequency (2-9 MHz) Convex Transducer for Children Including Fatty Liver.
    Yoon H; Kim J; Lim HJ; Kamiyama N; Oguri T; Koh H; Lee MJ
    Ultrasound Med Biol; 2022 Jun; 48(6):1070-1077. PubMed ID: 35296397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ultrasound in the diagnostics of fatty liver in obesity].
    Szebeni A; Tolvaj G; Stotz G
    Orv Hetil; 2010 Apr; 151(14):572-5. PubMed ID: 20332074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of ultrasonic attenuation with pathologic fat and fibrosis in liver disease.
    Lin T; Ophir J; Potter G
    Ultrasound Med Biol; 1988; 14(8):729-34. PubMed ID: 3062866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD.
    Han A; Zhang YN; Boehringer AS; Andre MP; Erdman JW; Loomba R; Sirlin CB; O'Brien WD
    Eur Radiol; 2019 Sep; 29(9):4699-4708. PubMed ID: 30783789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acoustic properties, centered on 20 MHZ, of an IEC agar-based tissue-mimicking material and its temperature, frequency and age dependence.
    Brewin MP; Pike LC; Rowland DE; Birch MJ
    Ultrasound Med Biol; 2008 Aug; 34(8):1292-306. PubMed ID: 18343021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat.
    Taylor KJ; Riely CA; Hammers L; Flax S; Weltin G; Garcia-Tsao G; Conn HO; Kuc R; Barwick KW
    Radiology; 1986 Jul; 160(1):65-71. PubMed ID: 3520657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers.
    Ghoshal G; Lavarello RJ; Kemmerer JP; Miller RJ; Oelze ML
    Ultrasound Med Biol; 2012 Dec; 38(12):2238-48. PubMed ID: 23062376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of the ultrasound attenuation index for noninvasive quantitative estimation of hepatic steatosis.
    Kwon HJ; Kim KW; Lee SJ; Kim SY; Lee JS; Kim HJ; Song GW; Kim SA; Yu ES; Lee J; Hwang S; Lee SG
    J Ultrasound Med; 2013 Feb; 32(2):229-35. PubMed ID: 23341377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonic characterization of porcine liver tissue at frequency between 25 to 55 MHz.
    Liu XZ; Gong XF; Zhang D; Ye SG; Rui B
    World J Gastroenterol; 2006 Apr; 12(14):2276-9. PubMed ID: 16610036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro classification of gallstones by quantitative echography.
    Goedegebure A; van der Steen AF; Thijssen JM
    Ultrasound Med Biol; 1992; 18(6-7):553-68. PubMed ID: 1413267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new system for in vivo assessment of the degree of nonlinear generation using the second harmonic component in echo signals.
    Fujii Y; Taniguchi N; Akiyama I; Tsao JW; Itoh K
    Ultrasound Med Biol; 2004 Nov; 30(11):1511-6. PubMed ID: 15588961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dependence of ultrasonic attenuation of liver on pathologic fat and fibrosis: examination with experimental fatty liver and liver fibrosis models.
    Suzuki K; Hayashi N; Sasaki Y; Kono M; Kasahara A; Fusamoto H; Imai Y; Kamada T
    Ultrasound Med Biol; 1992; 18(8):657-66. PubMed ID: 1440987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.